171 related articles for article (PubMed ID: 11449838)
41. Cytogenetic and molecular biology for acute leukemias at diagnosis: a cost/effectiveness comparison.
Tonnaire G; Gabert J; Lafage-Pochitaloff M; Mozziconacci MJ; Toiron Y; Sainty D; Maraninchi D; Moatti JP
Leuk Lymphoma; 1998 Jan; 28(3-4):363-70. PubMed ID: 9517507
[TBL] [Abstract][Full Text] [Related]
42. [Molecular biology diagnosis and monitoring in acute lymphoblastic leukemia and non-Hodgkin-lymphoma].
Svejgaard A; Madsen HO; Nyvold C; Ryder LP; Schmiegelow K
Ugeskr Laeger; 1996 Dec; 158(49):7101-2. PubMed ID: 8999621
[No Abstract] [Full Text] [Related]
43. How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.
Béné MC; Kaeda JS
Haematologica; 2009 Aug; 94(8):1135-50. PubMed ID: 19586938
[TBL] [Abstract][Full Text] [Related]
44. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review.
Potter MN; Cross NC; van Dongen JJ; Saglio G; Oakhill A; Bartram CR; Goldman JM
Leukemia; 1993 Aug; 7(8):1302-14. PubMed ID: 8350633
[TBL] [Abstract][Full Text] [Related]
45. Immunophenotypical detection of minimal residual disease in acute leukemia.
San Miguel JF; Ciudad J; Vidriales MB; Orfao A; Lucio P; Porwit-MacDonald A; Gaipa G; van Wering E; van Dongen JJ
Crit Rev Oncol Hematol; 1999 Dec; 32(3):175-85. PubMed ID: 10633847
[No Abstract] [Full Text] [Related]
46. Usefulness of cytochemical investigations in differential diagnosis and prognosis of acute leukemias.
Kołakowska-Polubiec K; Litwin J; Maj S; Bielecka B
Mater Med Pol; 1979; 11(2):125-31. PubMed ID: 513834
[No Abstract] [Full Text] [Related]
47. [Leukemias in lymphogranulomatosis and other malignant neoplasms].
Volkova MA; Chervonobab IuV; Frenkel MA
Sov Med; 1981; (4):83-9. PubMed ID: 7027459
[No Abstract] [Full Text] [Related]
48. [Molecular-genetic studies of gene dislocations in the differential diagnosis of lymphomas and leukemias].
Lubiński J
Patol Pol; 1989; 40(2):137-48. PubMed ID: 2700380
[TBL] [Abstract][Full Text] [Related]
49. BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays.
Wallace J; Zhou Y; Usmani GN; Reardon M; Newburger P; Woda B; Pihan G
Leukemia; 2003 Jul; 17(7):1411-3. PubMed ID: 12835732
[No Abstract] [Full Text] [Related]
50. Molecular pathology of leukemia and lymphoma.
Bagg A; Kallakury BV
Am J Clin Pathol; 1999 Jul; 112(1 Suppl 1):S76-92. PubMed ID: 10396303
[TBL] [Abstract][Full Text] [Related]
51. Low frequency of reverse transcription polymerase chain reaction-detectable chromosome aberrations in relapsed acute myeloid leukaemia: implications for detection of minimal residual disease.
van der Velden VH; Schoch C; Langerak AW; Schnittger S; Hoogeveen PG; van Dongen JJ
Br J Haematol; 2001 Jun; 113(4):1082-3. PubMed ID: 11442511
[No Abstract] [Full Text] [Related]
52. Detection of minimal residual disease in acute and chronic leukemias.
Radich J
Curr Opin Hematol; 1996 Jul; 3(4):310-4. PubMed ID: 9372093
[TBL] [Abstract][Full Text] [Related]
53. The immunodiagnosis of leukemia.
Pisciotta AV; Cronkite C; Pryor S; Wilson B
Transplant Proc; 1980 Mar; 12(1):198-204. PubMed ID: 6989057
[No Abstract] [Full Text] [Related]
54. [Molecular genetics--valuable diagnostic complement in cases of lymphomas/leukemias].
Lindh J; Roos G
Lakartidningen; 1991 Feb; 88(8):641-4. PubMed ID: 2002732
[No Abstract] [Full Text] [Related]
55. Proceedings of the Third International Symposium on Minimal Residual Disease in Acute Leukemia. 28-30 March, 1990, Rotterdam, The Netherlands.
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():1-134. PubMed ID: 2390635
[No Abstract] [Full Text] [Related]
56. Immunologic classification of the acute non-granular leukemias in the city of Puebla, Mexico: its value in the diagnosis and prognosis.
Ruiz-Argüelles GJ; Marín-López A; Ruiz-Argüelles A
Rev Invest Clin; 1987; 39(2):143-7. PubMed ID: 3659626
[No Abstract] [Full Text] [Related]
57. [Immunologic characterization of acute leukemias. Towards a routine use?].
Vannier JP; Schaison G
Arch Fr Pediatr; 1989 Jan; 46(1):53-7. PubMed ID: 2653265
[No Abstract] [Full Text] [Related]
58. [A family with a sister and brother affected by acute leukemia (author's transl)].
Ohyashiki K; Ohsumi A; Ito H; Umehara S; Ohyashiki J; Yunokawa K; Miyasaka Y; Osamura S; Miyasaka Y; Oshimura M
Rinsho Ketsueki; 1982 Mar; 23(3):377-84. PubMed ID: 6955537
[No Abstract] [Full Text] [Related]
59. [Problems of terminology, classification and reliability of cytomorphologic diagnosis of acute leukemias (author's transl)].
Hauptmann E; Crepinko I; Ljubimir K
Lijec Vjesn; 1978 Jun; 100(6):361-3. PubMed ID: 703489
[No Abstract] [Full Text] [Related]
60. A multifaceted approach to diagnosis and classification of acute leukemia.
McKenna RW
Arch Pathol Lab Med; 1991 Apr; 115(4):328-30. PubMed ID: 2012493
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
